Gene · 3745
Papers1,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells by the atypical antipsychotic agent sertindole. | J Appl Toxicol | 2024 | 37786982 | PubTator, text mining | PubMed |
| Presynaptic endoplasmic reticulum architecture and hereditary spastic paraplegia. | Neural Regen Res | 2024 | 37721265 | PubTator, text mining | PubMed |
| Snake Venom: A Promising Source of Neurotoxins Targeting Voltage-Gated Potassium Channels. | Toxins (Basel) | 2023 | 38251229 | PubTator, text mining | PubMed |
| Comprehensive exploration of JQ1 and GSK2801 targets in breast cancer using network pharmacology and molecular modeling approaches. | Comput Struct Biotechnol J | 2023 | 38213901 | PubTator, text mining | PubMed |
| Stress-induced translation of KCNB1 contributes to the enhanced synaptic transmission of the lateral habenula. | Front Cell Neurosci | 2023 | 38193032 | PubTator, text mining | PubMed |
| Lysicamine Reduces Protein Kinase B (AKT) Activation and Promotes Necrosis in Anaplastic Thyroid Cancer. | Pharmaceuticals (Basel) | 2023 | 38139812 | PubTator, text mining | PubMed |
| Visualization and Characterization of the Brain Regional Heterogeneity of Astrocyte-Astrocyte Structural Interactions by Using Improved Iontophoresis with Dual-Fluorescent Dyes. | Brain Sci | 2023 | 38137092 | PubTator, text mining | PubMed |
| Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial. | Sci Rep | 2023 | 38049525 | PubTator, text mining | PubMed |
| Activation of cyclin-dependent kinase 5 broadens action potentials in human sensory neurons. | Mol Pain | 2023 | 37982142 | PubTator, text mining | PubMed |
| Adam, amigo, brain, and K channel. | Biophys Rev | 2023 | 37975011 | PubTator, text mining | PubMed |
| The formation of KV2.1 macro-clusters is required for sex-specific differences in L-type CaV1.2 clustering and function in arterial myocytes. | Commun Biol | 2023 | 37963972 | PubTator, text mining | PubMed |
| Parvimonas micra, an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes. | Gut Microbes | 2023 | 37842920 | PubTator, text mining | PubMed |
| Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. | Int J Mol Sci | 2023 | 37834297 | PubTator, text mining | PubMed |
| Complexity in Genetic Epilepsies: A Comprehensive Review. | Int J Mol Sci | 2023 | 37834053 | PubTator, text mining | PubMed |
| Analysis of Free Circulating Messenger Ribonucleic Acids in Serum Samples from Late-Onset Spinal Muscular Atrophy Patients Using nCounter NanoString Technology. | Cells | 2023 | 37830588 | PubTator, text mining | PubMed |
| Diminishing neuronal acidification by channelrhodopsins with low proton conduction. | Elife | 2023 | 37801078 | PubTator, text mining | PubMed |
| Noteworthy perspectives on microglia in neuropsychiatric disorders. | J Neuroinflammation | 2023 | 37794488 | PubTator, text mining | PubMed |
| An in silico investigation of Kv2.1 potassium channel: Model building and inhibitors binding sites analysis. | Mol Inform | 2023 | 37793122 | PubTator, text mining | PubMed |
| Selective transduction and photoinhibition of pre-Bötzinger complex neurons that project to the facial nucleus in rats affects nasofacial activity. | Elife | 2023 | 37772793 | PubTator, text mining | PubMed |
| The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data. | Biomedicines | 2023 | 37760888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3745/papers?page=5